Simpson Thacher & Bartlett advised Cisco Systems, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the underwriters. Cisco Systems, Inc. (Nasdaq:...
Cisco Systems’ $13.5 Billion Senior Notes Offering
IDEAYA Biosciences’ $350 Million At-the-Market Offering
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised Jefferies LLC, as sales agent. IDEAYA Biosciences, Inc. (NYSE: IDYA)...
IDEAYA Biosciences’ $143.8 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the several underwriters. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)...
RAPT Therapeutics’ $150 Million At-The-Market Offering
Cooley advised RAPT Therapeutics, Inc. and Davis Polk & Wardwell advised the sales agents on the offering. RAPT Therapeutics, Inc. (Nasdaq:RAPT) announced the SEC-registered at-the-market offering of its common...
Recursion Pharmaceuticals’ $300 Million At-The-Market Offering
Wilson Sonsini Goodrich & Rosati advised Recursion Pharmaceuticals, Inc.; and Davis Polk & Wardwell LLP advised Jefferies LLC, as sales agent, in the offering. Recursion Pharmaceuticals,...
IDEAYA Biosciences’ $250 Million At-the-Market Offering
Latham & Watkins LLP advised IDEAYA Biosciences, Inc., while Davis Polk & Wardwell LLP advised Jefferies LLC in the offering. IDEAYA Biosciences, Inc. announced the SEC-registered at-the-market...
AN2 Therapeutics’ $100 Million At-The-Market Offering
Cooley advised AN2 Therapeutics on the offering, and Davis Polk advised the sales agent. AN2 Therapeutics, Inc. announced the SEC-registered at-the-market offering of its common stock...
Pacific Biosciences’ $201.25 Million Stock Offering
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...
Recursion Pharmaceuticals’ $150 Million Private Placement
Davis Polk advised the placement agents in the transaction. Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the...
IDEAYA Biosciences’ $80 Million Common Stock Offering
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
Carvana’s $3.275 Billion Senior Notes Offering
Davis Polk advised J.P. Morgan Securities as representative of the initial purchasers on the offering. Carvana Co. announced its debt offering of $3.275 billion aggregate principal amount...
Carvana’s $1.25 Billion Shares Offering
Kirkland & Ellis advised Caravan, while Davis Polk advised the representatives of the several underwriters in the offering. Carvana, Co. executed its offering of 15,625,000 shares of...